Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials

IMPORTANCE: For men with metastatic castration-resistant prostate cancer (mCRPC) whose condition is responding to enzalutamide, new unconfirmed bone lesions detected at posttreatment scinitigraphy may reflect an osteoblastic reaction that represents healing, known as pseudoprogression, which can lea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Oncol
Hlavní autoři: Armstrong, Andrew J., Al-Adhami, Mohammed, Lin, Ping, Parli, Teresa, Sugg, Jennifer, Steinberg, Joyce, Tombal, Bertrand, Sternberg, Cora N., de Bono, Johann, Scher, Howard I., Beer, Tomasz M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990871/
https://ncbi.nlm.nih.gov/pubmed/31830211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.4636
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky